Image-Guided Brain Surgery [0.03%]
图像引导的脑手术
Stephanie Schipmann-Miletić,Walter Stummer
Stephanie Schipmann-Miletić
In neurosurgery, the extent of resection plays a critical role, especially in the management of malignant gliomas. These tumors are characterized through a diffuse infiltration into the surrounding brain parenchyma. Delineation between tumo...
Non-invasive Imaging Techniques: From Histology to In Vivo Imaging : Chapter of Imaging in Oncology [0.03%]
非侵入性成像技术：从组织学到活体成像：肿瘤学成像中的章节内容
Thomas Bocklitz,Anja Silge,Hyeonsoo Bae et al.
Thomas Bocklitz et al.
In this chapter, we will introduce and review molecular-sensitive imaging techniques, which close the gap between ex vivo and in vivo analysis. In detail, we will introduce spontaneous Raman spectral imaging, coherent anti-Stokes Raman scat...
Image-Guided Radiooncology: The Potential of Radiomics in Clinical Application [0.03%]
影像引导放射肿瘤学： radiomics 的临床应用潜力
Jan C Peeken,Benedikt Wiestler,Stephanie E Combs
Jan C Peeken
Medical imaging plays an imminent role in today's radiation oncology workflow. Predominantly based on semantic image analysis, malignant tumors are diagnosed, staged, and therapy decisions are made. The field of "radiomics" promises to extr...
Nathalie Lassau
Nathalie Lassau
Neovascularization is a key stage in the growth of malignancies beyond 2-3 mm3. This neoangiogenesis is an important target for novel anticancer treatments [1], and many new antiangiogenesis or antivascular treatments aim at destroying or l...
Clinical PET/MR [0.03%]
临床PET/MR影像技术
Wolfgang Weber
Wolfgang Weber
Oncologic imaging has been a major focus of clinical research on PET/MR over the last 10 years. Studies so far have shown that PET/MR with 18F-Fluorodeoxyglucose (FDG) overall provides a similar accuracy for tumor staging as FDG PET/CT. The...
Clinical MR Biomarkers [0.03%]
临床磁共振生物标志物
Daniel Paech,Heinz-Peter Schlemmer
Daniel Paech
Non-invasive magnetic resonance imaging (MRI) techniques are increasingly applied in the clinic with a fast growing body of evidence regarding its value for clinical decision making. In contrast to biochemical or histological markers, the k...
Non-FDG PET/CT [0.03%]
非FDG PET/CT
Egesta Lopci,Stefano Fanti
Egesta Lopci
The major applications for molecular imaging with PET in clinical practice concern cancer imaging. Undoubtedly, 18F-FDG represents the backbone of nuclear oncology as it remains so far the most widely employed positron emitter compound. The...
Juliane Becker,Sarah M Schwarzenböck,Bernd J Krause
Juliane Becker
Molecular imaging with positron emission tomography (PET) using tumour-seeking radiopharmaceuticals has gained wide acceptance in oncology with many clinical applications. The hybrid imaging modality PET/CT (computed tomography) allows asse...
Dirk Grosenick,Christoph Bremer
Dirk Grosenick
Optical imaging offers a high potential for noninvasive detection and therapy of cancer in humans. Recent advances in instrumentation for diffuse optical imaging have led to new capabilities for the detection of cancer in highly scattering ...
Philipp Ritt,Torsten Kuwert
Philipp Ritt
The continuous development of SPECT over the past 50 years has led to improved image quality and increased diagnostic confidence. The most influential developments include the realization of hybrid SPECT/CT devices, as well as the implement...